These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6838217)
21. The control of delta-aminolevulinic acid synthetase in rat liver mitochondria. Effect of pyrazole on the apparent 'induction'. Beattie DS; Patton GM; Rubin E Enzyme; 1973; 16(1):252-7. PubMed ID: 4791046 [No Abstract] [Full Text] [Related]
22. Mechanism of allylisopropylacetamide-induced increase of delta-aminolevulinate synthetase in liver mitochondria. Effects of administration of glucose, cyclic AMP, and some hormones related to glucose metabolism. Kim HJ; Kikuchi G Arch Biochem Biophys; 1974 Sep; 164(1):293-304. PubMed ID: 4154726 [No Abstract] [Full Text] [Related]
23. Studies on the conversion of the cytosol delta-aminolevulinate synthetase to the mitochondrial enzyme. Kikuchi G; Ohashi A; Hayashi N Ann Clin Res; 1976; 8 Suppl 17():74-82. PubMed ID: 1008501 [TBL] [Abstract][Full Text] [Related]
24. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria. Blum I; Schoenfeld N; Atsmon A Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745 [No Abstract] [Full Text] [Related]
25. Delta-Aminolevulinic acid synthase from chick embryo liver mitochondria. II. Immunochemical correlation between synthesis and activity in induction and repression. J Biol Chem; 1976 Mar; 251(5):1347-53. PubMed ID: 815257 [TBL] [Abstract][Full Text] [Related]
26. Effect of heme on allylisopropylacetamide-induced changes in heme and drug metabolism in the rhesus monkey (Macaca mulatta). Muller-Eberhard U; Eiseman JL; Foidart M; Alvares AP Biochem Pharmacol; 1983 Dec; 32(24):3765-9. PubMed ID: 6689267 [TBL] [Abstract][Full Text] [Related]
27. The influence of allyl isopropyl acetamide on d-aminolevulinic acid synthetase and cytochrome P-450. Klinger W; Müller D Acta Biol Med Ger; 1980; 39(1):107-112. PubMed ID: 7424328 [TBL] [Abstract][Full Text] [Related]
28. Purification and some properties of delta-aminolevulinate synthase from the rat liver cytosol fraction and immunochemical identity of the cytosolic enzyme and the mitochondrial enzyme. Nakakuki M; Yamauchi K; Hayashi N; Kikuchi G J Biol Chem; 1980 Feb; 255(4):1738-45. PubMed ID: 6766453 [No Abstract] [Full Text] [Related]
29. Mitochondrial metabolism in porphyric rat liver. Miyahara M; Hirata K; Tada H; Seno S Biochim Biophys Acta; 1973 Oct; 325(1):47-53. PubMed ID: 4358812 [No Abstract] [Full Text] [Related]
30. Effect of glucose on the induction of delta-aminolevulinic acid synthase and ferrochelatase in isolated rat hepatocytes by allylisopropylacetamide. Cánepa ET; Llambías EB; Grinstein M Biochim Biophys Acta; 1984 May; 804(1):8-15. PubMed ID: 6326846 [TBL] [Abstract][Full Text] [Related]
31. Enzymatic formation of zinc-protoporphyrin by rat liver and its potential effect on hepatic heme metabolism. Bloomer JR; Reuter RJ; Morton KO; Wehner JM Gastroenterology; 1983 Sep; 85(3):663-8. PubMed ID: 6873612 [TBL] [Abstract][Full Text] [Related]
32. Evidence for the catabolism of polychlorinated biphenyl-induced cytochrome P-448 by microsomal heme oxygenase, and the inhibition of delta-aminolevulinate dehydratase by polychlorinated biphenyls. Maines MD J Exp Med; 1976 Dec; 144(6):1509-19. PubMed ID: 826600 [TBL] [Abstract][Full Text] [Related]
33. Studies in porphyria. VI. Biosynthesis of porphyrins in mammalian skin and in the skin of porphyric patients. Bickers DR; Keogh L; Rifkind AB; Harber LC; Kappas A J Invest Dermatol; 1977 Jan; 68(1):5-9. PubMed ID: 830770 [TBL] [Abstract][Full Text] [Related]
34. Control of 5-aminolevulinate synthase in animals. May BK; Borthwick IA; Srivastava G; Pirola BA; Elliott WH Curr Top Cell Regul; 1986; 28():233-62. PubMed ID: 3539534 [TBL] [Abstract][Full Text] [Related]
35. Purification and properties of solubilized mitochondrial -aminolevulinic acid synthetase and comparison with the cytosol enzyme. Whiting MJ; Elliott WH J Biol Chem; 1972 Nov; 247(21):6818-26. PubMed ID: 5082128 [No Abstract] [Full Text] [Related]
36. Soluble hepatic delta-aminolevulinic acid synthetase: end-product inhibition of the partially purified enzyme. Sholnick PL; Hammaker LE; Marver HS Proc Natl Acad Sci U S A; 1969 May; 63(1):65-70. PubMed ID: 5257968 [TBL] [Abstract][Full Text] [Related]
37. Cimetidine suppresses chemically induced experimental hepatic porphyria. Marcus DL; Nadel H; Lew G; Freedman ML Am J Med Sci; 1990 Oct; 300(4):214-7. PubMed ID: 2248274 [TBL] [Abstract][Full Text] [Related]
38. Metabolization of porphyrinogenic agents in brain: involvement of the phase I drug metabolizing system. A comparative study in liver and kidney. Lavandera JV; Batlle AM; Buzaleh AM Cell Mol Neurobiol; 2007 Sep; 27(6):717-29. PubMed ID: 17676386 [TBL] [Abstract][Full Text] [Related]
39. The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats. Tokola O; Lindén IB; Tenhunen R Pharmacol Toxicol; 1987 Jul; 61(1):75-8. PubMed ID: 3628186 [TBL] [Abstract][Full Text] [Related]
40. The influence of postnatal development on drug-induced hepatic porphyria and the synthesis of cytochrome P-450. A biochemical and morphological study. Song CS; Moses HL; Rosenthal AS; Gelb NA; Kappas A J Exp Med; 1971 Nov; 134(5):1349-71. PubMed ID: 5112207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]